Owing to the strong neutron absorption of 151Eu, 151Eu free 153EuMnO3-δ has been synthesized to collect the neutron diffraction data for analyzing the magnetic structure of EuMnO3-δ. The obtained neutron diffraction data of 153EuMnO3-δ indicates that the magnetic diffraction peaks corresponding to cAAFM (canted A-type antiferromagnetic) phase can be observed, but the magnetic diffraction peaks corresponding to expected ICAFM (incommensurate antiferromagnetic) phase may be too weak to be observed.
A series of oxides in the Mn3O4-Fe2O3 system have been synthesized at 1200°C in air, followed by quenching to room temperature. Three solid solutions, Mn3-3xFe3xO4 (0.00£x£0.278), Mn3-3xFe3xO4(0.291£ x£0.667), and Mn2-2xFe2xO3 (0.89£x£1.00), have been identified by powder X-ray diffraction (XRD). Rietveld refinement of the XRD data show that the solids belong to the hausmannite phase with the space group I41/ amd, the spinel phase with the space group Fd3m, and the hematite phase with the space group R3c, respectively. Between these are two-phase regions. 57 Fe Mössbauer spectra indicate that the valence state of Fe in the three solid solutions is +3; in addition, there are two crystallographically independent Fe 3 + ions in the unit cells of the hausmannite and spinel phases, and one Fe 3+ in the hematite phase. Analyses of 57 Fe Mössbauer spectra and X-ray photoelectron spectra (XPS) revealed that a formula of Mn 2+ 1-xFex 3+ [Mnx 2+ Fe 3+ x Mn 3+ 2-3x] O4 describes the cation distribution of both the hausmannite and spinel phases, but that for the hematite [Article] www.whxb.pku.edu.cn
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.